134 related articles for article (PubMed ID: 20823419)
1. Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes.
Murali R; Desilva C; Thompson JF; Scolyer RA
J Clin Oncol; 2010 Oct; 28(29):4441-9. PubMed ID: 20823419
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
[TBL] [Abstract][Full Text] [Related]
4. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
[TBL] [Abstract][Full Text] [Related]
5. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
6. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
[TBL] [Abstract][Full Text] [Related]
7. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
[TBL] [Abstract][Full Text] [Related]
10. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
11. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.
Dewar DJ; Newell B; Green MA; Topping AP; Powell BW; Cook MG
J Clin Oncol; 2004 Aug; 22(16):3345-9. PubMed ID: 15310779
[TBL] [Abstract][Full Text] [Related]
12. Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma.
Cadili A; Scolyer RA; Brown PT; Dabbs K; Thompson JF
Ann Surg Oncol; 2010 Nov; 17(11):3015-20. PubMed ID: 20552405
[TBL] [Abstract][Full Text] [Related]
13. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
Govindarajan A; Ghazarian DM; McCready DR; Leong WL
Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
[TBL] [Abstract][Full Text] [Related]
14. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
15. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.
Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K
J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281
[TBL] [Abstract][Full Text] [Related]
16. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
Pearlman NW; McCarter MD; Frank M; Hurtubis C; Merkow RP; Franklin WA; Gonzalez R; Lewis K; Roaten JB; Robinson WA
Am J Surg; 2006 Dec; 192(6):878-81. PubMed ID: 17161112
[TBL] [Abstract][Full Text] [Related]
17. [Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards].
Arens A; Osinga J; Schwipper V; Schober O; Tilkorn H; Liebau J
Chirurg; 2003 Jul; 74(7):665-70. PubMed ID: 12883795
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
Glumac N; Hocevar M; Zadnik V; Snoj M
J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
[TBL] [Abstract][Full Text] [Related]
19. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
